GEORGETOWN, TEXAS (PRWEB) JANUARY 11, 2018 Last month, the Food and Drug Administration cleared ReBOSSIS®, the only biosynthetic bone scaffold with electrospun microfiber construction, for use in posterolateral spine procedures. “Having ReBOSSIS® used in these types of procedures reaffirms its place in today’s biologic market,” says Doris Blake, president and COO of ORTHOReBIRTH USA, a wholly […]